Cetera Advisor Networks’s Celldex Therapeutics CLDX Stock Holding History

Cetera Advisor Networks’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-28	Closed	–	–	1520
2020 Q2	$0	Buy	+28	New	+$124	﹤0.01%	3437
2017 Q3	–	Sell	-726	Closed	-$27K	–	919
2017 Q2	$27K	Hold	726	–	–	﹤0.01%	914
2017 Q1	$38K	Hold	726	–	–	﹤0.01%	911
2016 Q4	$37K	Hold	726	–	–	﹤0.01%	858
2016 Q3	$44K	Buy	726 +47	+7%	+$2.93K	﹤0.01%	1023
2016 Q2	$44K	Buy	+679	New	+$43.1K	﹤0.01%	826
2013 Q4	–	Sell	-576	Closed	-$305K	–	766
2013 Q3	$305K	Buy	+576	New	+$198K	0.03%	483

Other funds holding CLDX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Cetera Advisor Networks's CLDX Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Celldex Therapeutics (CLDX) in Q3 2020, closing a stake of 28 shares.

Cetera Advisor Networks first reported a position in CLDX in Q3 2013 and held it in 7 quarters. The position peaked at $305K in Q3 2013. 91 funds tracked by Wall St. Rank hold CLDX as of Q3 2020.

Cetera Advisor Networks reported no remaining Celldex Therapeutics position as of Q3 2020 after selling out during the quarter.
Cetera Advisor Networks sold 28 Celldex Therapeutics shares in Q3 2020.
Cetera Advisor Networks first reported a position in Celldex Therapeutics in Q3 2013 and held it in 7 quarters.
Cetera Advisor Networks's Celldex Therapeutics position peaked at $305K in Q3 2013.
91 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.